| Literature DB >> 35927707 |
Theresa F Wechsler1, Melissa Schmidmeier2, Stefanie Biehl2, Jennifer Gerczuk2, Fiorella-Maria Guerrero-Cerda2, Andreas Mühlberger2.
Abstract
BACKGROUND: Many studies have previously compared the prevalence or sample means of distress and mental health problems from before to during the COVID-19 pandemic, while results on changes at the individual-level, and regarding multiple outcome measures are demanded.Entities:
Keywords: Anxiety; COVID-19; Depression; Generalized anxiety; Health anxiety; Mental health; Panic disorder; Pathological worry; Posttraumatic stress; Stress
Mesh:
Year: 2022 PMID: 35927707 PMCID: PMC9354380 DOI: 10.1186/s12888-022-04148-y
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 4.144
Fig. 1Milestone dates of the early phase of the COVID-19 pandemic and Bavarian lockdown measures. The figure reports milestone dates concerning the spreading of SARS-CoV-2 and the early phase of the COVID-19 pandemic [1, 2], and concerning lockdown measures in Bavaria [3–5, 7–9, 11, 12]. Between April 10–27, 2020 (recruitment and data collection phase), state measures of stress and mental health problems during lockdown, as well as retrospective measures comparing the current state to the last six months before knowing about SARS-CoV-2 were conducted
Stress and mental health during first COVID-19 lockdown and changes compared to before the pandemic
| Variables | Total samplea | Change category subsamplesd | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Perceived decrease | Perceived no change | Perceived increase | |||||||||
| Scoreb | Clin. rel.c | Scoreb | Clin. rel.c | Scoreb | Clin. rel.c | Scoreb | Clin. rel.c | ||||
| Perceived stress | |||||||||||
| Total | 39.66 (21.44) | 143 (36.1) | 60 (15.2) | 24.42 (17.25) | 6 (1.5) | 233 (58.8) | 34.34 (17.42) | 57 (14.4) | 103 (26.0) | 60.57 (16.62) | 80 (20.2) |
| 36.75 (25.78) | 140 (35.4) | 32 (8.1) | 25.42 (23.0) | 5 (1.3) | 224 (56.6) | 26.37 (19.23) | 39 (9.8) | 140 (35.4) | 55.95 (24.54) | 96 (24.2) | |
| 40.76 (27.02) | 171 (43.2) | 66 (16.7) | 21.62 (20.62) | 8 (2.0) | 203 (51.3) | 32.38 (21.51) | 59 (14.9) | 127 (32.1) | 64.09 (21.76) | 104 (26.3) | |
| 52.61 (23.89) | 141 (35.6) | 151 (38.1) | 37.79 (20.45) | 94 (23.7) | 205 (51.8) | 60.59 (21.32) | 43 (10.9) | 40 (10.1) | 67.67 (19.42) | 4 (1.0) | |
| 33.74 (25.31) | 132 (33.3) | 155 (39.1) | 18.67 (17.64) | 16 (4.0) | 169 (42.7) | 34.75 (20.59) | 57 (14.4) | 72 (18.2) | 63.80 (21.69) | 59 (14.9) | |
| Mental health problems | |||||||||||
| Depression | 4.68 (4.70) | 55 (13.9) | 14 (3.5) | 5.57 (5.77) | 2 (0.5) | 279 (70.5) | 2.94 (3.20) | 12 (3.0) | 103 (26.0) | 9.29 (4.84) | 41 (10.4) |
| PTSD | 19.57 (12.88) | 142 (35.9) | 12 (3.0) | 19.25 (15.69) | 3 (0.8) | 283 (71.5) | 15.59 (10.59) | 66 (16.7) | 101 (25.5) | 30.75 (11.87) | 73 (18.4) |
| Anxiety | 2.16 (2.90) | 42 (10.6) | 9 (2.3) | 3.22 (4.52) | 2 (0.5) | 365 (92.2) | 1.76 (2.28) | 22 (5.6) | 22 (5.6) | 8.36 (4.08) | 18 (4.5) |
| Path. Worry | 37.83 (18.73) | 83 (21.0) | 11 (2.8) | 36.45 (16.48) | 2 (0.5) | 346 (87.4) | 35.51 (17.81) | 54 (13.6) | 39 (9.8) | 58.82 (13.88) | 27 (6.8) |
| Health Anxiety | 17.19 (11.07) | 113 (28.5) | 3 (0.8) | 23.33 (6.66) | 1 (0.3) | 364 (91.9) | 15.86 (10.24) | 86 (21.7) | 29 (7.3) | 33.28 (8.39) | 26 (6.6) |
COVID-19 coronavirus disease 2019, PTSD posttraumatic stress disorder, Path pathological, Clin. rel clinically relevant
a N=396 participants (100.0%)
b Questionnaire scores for PSQ-20 (Perceived-Stress-Questionnaire) total, and the subscales worries, tension, joy, and demands (each range 0–100), DASS21 (Depression-Anxiety-Stress-Scales) subscales depression and anxiety (each range 0–21), PTSS-10 (Posttraumatic-Symptom-Scale; range 0–60), PSWQ-PW (Penn-State-Worry-Questionnaire-Past-Week; range 0–90), and MK-HAI (German-modified-Health-Anxiety-Inventory; range 0–56), all assessing the participants’ state during lockdown
c Number and percentage (within the total sample) of participants with clinically relevant questionnaire scores during lockdown according to cut-offs stated by the questionnaire authors (≥10 for DASS21 depression, ≥24 for PTSS-10, and ≥6 for DASS21 anxiety), or according to criterion c thresholds for clinical significance calculated with reference to clinical samples from the literature (≥46.37 for PSQ-20 total, ≥44.84 for PSQ-20 worries, ≥45.77 for PSQ-20 tension, ≥44.66 for PSQ-20 joy, ≥40.02 for PSQ-20 demands, ≥54.54 for PSWQ-PW, and ≥23.93 for MK-HAI)
d Adapted versions of the stated questionnaires were used to measure perceived changes during first lockdown in comparison to before the COVID-19 pandemic on item level (–2 much less than before corona; +2 much more than before corona). Change indices (–2 strong decrease; +2 strong increase) were calculated for each participant and each outcome variable by averaging the change values for the respective questionnaire items, and were grouped into three change categories (–2.00 to –0.50 decrease; –0.49 to +0.49 no change; +0.50 to +2.00 increase)
e Absolute and relative frequencies of participants with a perceived decrease, no change, or increase in perceived stress and mental health problems during first lockdown in comparison to before the COVID-19 pandemic
Sociodemographic, pandemic-associated, and health-related sample characteristics
| Characteristics | Total sample ( |
|---|---|
| Sex, | |
| Female | 278 (70.2) |
| Male | 116 (29.3) |
| Diverse | 2 (0.5) |
| Age categories, | |
| 18–30 | 138 (34.8) |
| 31–40 | 101 (25.5) |
| 41–50 | 54 (13.6) |
| 51–65 | 79 (19.9) |
| 66–80+ | 24 (6.1) |
| Relationship status, | |
| In a relationship | 291 (73.5) |
| Not in a relationship | 105 (26.5) |
| Household size, | |
| Living together with at least one other person | 326 (82.3) |
| Living alone | 70 (17.7) |
| Highest professional qualification, | |
| No professional qualification | 51 (12.9) |
| Completed vocational training | 81 (20.5) |
| Master / technician / comparable | 28 (7.1) |
| University of applied sciences degree | 65 (16.5) |
| University degree | 170 (43.0) |
| Current employment status, | |
| Student | 71 (17.9) |
| Employed | 250 (63.1) |
| Retired or privateer | 31 (7.8) |
| Not employedb | 30 (7.6) |
| Other | 14 (3.5) |
| Change in employment status due to lockdown, | |
| No change | 235 (59.3) |
| Furlough | 21 (5.3) |
| Reduction of occupational activity | 83 (21.0) |
| Discontinuation of occupational activity | 27 (6.8) |
| Elevation of occupational activity | 30 (7.6) |
| Work setting during lockdown, | |
| Home-office (without childcare) | 137 (34.6) |
| Home-office (additional childcare) | 25 (6.3) |
| At-place (low contact) | 50 (12.6) |
| At-place (high contact) | 35 (8.8) |
| At-place, medical area (no COVID-19 patients) | 35 (8.8) |
| At-place, medical area (COVID-19 patients) | 20 (5.1) |
| (Currently) not workingd | 94 (23.7) |
| Full day childcare responsibility during lockdown, | |
| Yes | 65 (16.4) |
| No | 331 (83.6) |
| Live-contact with close person within last week, | |
| Yes | 249 (62.9) |
| No | 147 (27.1) |
| Fear of losing one’s livelihood – score (1-5), | 2.09 (1.09) |
| Fear and worries COVID-19 self – score (1-7)e, | 3.06 (1.29) |
| Fear and worries COVID-19 relatives – score (1-7)f, | 4.59 (1.54) |
| Current mental health treatmentg, | |
| Yes | 55 (14.0) |
| No | 338 (85.4) |
| Chronic physical diseasesi, | |
| Yes | 118 (29.8) |
| No | 278 (70.2) |
COVID-19 coronavirus disease 2019
a One missing value, n=395
b Includes being housewife/husband, on permanent sick leave/unable to work, permanently jobless, or welfare recipient
c Percentages do not add to 100% due to rounding
d Includes not having an occupation or not being a student, as well as sick-leave and lockdown-associated furlough
e An average score over four rating items including body checking on COVID-19 associated symptoms, disconcertment in case of sensing COVID-19 associated symptoms, fear of own illness with COVID-19, and fear of own death from COVID-19 (item values 1–7) was calculated
f An average score over three rating items including fear of illness of a relative with COVID-19, fear of a relative’s death from COVID-19, and fear of not being able to care for relatives being ill with COVID-19 (item values 1–7) was calculated
g Includes current psychiatric, psychotherapeutic, or psychopharmacological treatment
h Three missing values, n=393
i Includes cardiovascular diseases, respiratory diseases, diabetes, liver or kidney diseases, carcinosis, or diseases of immunity
Fig. 2Perceived changes in stress and clinical relevance during first COVID-19 lockdown. N=396 adult participants. Lengths of the single bars (comprising shaded and non-shaded parts) represent the relative frequencies of individually perceived decreases, no changes, and increases in subareas of perceived stress during first lockdown in comparison to before the COVID-19 pandemic. Lengths of the shaded parts within the single bars represent the respective percentage of participants whose level of perceived stress during lockdown reached clinical relevance thresholds. The non-shaded parts of the single bars represent the respective percentage of participants whose level of perceived stress during lockdown was below clinical relevance thresholds. To determine frequencies of perceived decreases, no changes, and increases in subscales of perceived stress, a modified version of the PSQ-20 was used to assess how people feel their stress has changed during lockdown in comparison to before the pandemic on item level (change values; –2 much less than before corona; +2 much more than before corona). Change indices (–2 strong decrease; +2 strong increase) were calculated for each participant and each outcome variable by averaging the change values for the respective subscales’ questionnaire items, and were grouped into three change categories (–2.00 to –0.50 decrease; –0.49 to +0.49 no change; +0.50 to +2.00 increase). The original version of PSQ-20 was used to measure the intensity of worries, tension, joy, and demands during first COVID-19 lockdown. To determine the clinical relevance of these subscales of perceived stress during lockdown, the participants’ questionnaire scores were classified as above or below clinical significance thresholds calculated in reference to a clinical sample from the literature (≥46.37 for PSQ-20 total, ≥44.84 for PSQ-20 worries, ≥45.77 for PSQ-20 tension, ≥44.66 for PSQ-20 joy, and ≥40.02 for PSQ-20 demands). The subscale joy was inverted for presentation in this figure, indicating lack of joy.
Fig. 3Perceived changes in mental health problems and clinical relevance during first COVID-19 lockdown. N=396 adult participants. Lengths of the single bars (comprising shaded and non-shaded parts) represent the relative frequencies of individually perceived decreases, no changes, and increases in mental health problems during first lockdown in comparison to before the COVID-19 pandemic. Lengths of the shaded parts within the single bars represent the respective percentage of participants whose level of symptom severity during lockdown reached clinical relevance thresholds. The non-shaded parts of the single bars represent the respective percentage of participants whose symptom level was below clinical relevance thresholds. To determine frequencies of perceived decreases, no changes, and increases in mental health problems, modified versions of the questionnaires DASS21 depression, PTSS10, DASS21 anxiety, PSWQ-PW, and MK-HAI were used to assess how people feel their mental health has changed during lockdown in comparison to before the pandemic on item level (change values; –2 much less than before corona; +2 much more than before corona). Change indices (–2 strong decrease; +2 strong increase) were calculated for each participant and each outcome variable by averaging the change values for the respective questionnaire items, and were grouped into three change categories (–2.00 to –0.50 decrease; –0.49 to +0.49 no change; +0.50 to +2.00 increase). The severity of symptoms during lockdown was measured using the original questionnaires (DASS21 depression, PTSS-10, DASS21 anxiety, PSWQ-PW, and MK-HAI). To determine the clinical relevance of the symptom severity, the participants’ questionnaire scores were classified as above or below cut-offs stated by the questionnaire authors (≥10 for DASS21 depression, ≥24 for PTSS-10, and ≥6 for DASS21 anxiety), or as above or below clinical significance thresholds calculated in reference to clinical samples from the literature (≥54.54 for PSWQ-PW, and ≥23.93 for MK-HAI)
Fig. 4Perceived changes in specific and non-specific PTSD symptoms during compared to before the COVID-19 pandemic. N=396 adult participants. The symbols indicate the relative frequencies of participants reporting a decrease, no change, or increase in different posttraumatic stress disorder (PTSD) symptoms. To determine frequencies of individually perceived decreases, no changes, and increases, a modified version of the 10-item Posttraumatic Symptom Scale (PTSS-10) was used to assess how people feel symptoms have changed during lockdown in comparison to before the pandemic on item level. For each participant, the change values for the single questionnaire items (–2 much less than before corona; +2 much than before corona) were grouped into three change categories (–2.00 to –0.50 decrease, –0.49 to +0.49 no change, +0.50 to +2.00 increase). Jumpiness, fear of recollection, and nightmares were classified as specific symptoms of PTSD, all other PTSS-10 symptoms as non-specific PTSD symptoms [47]